Etiology of acute bacterial meningitis in Chilean children from 1989 to 1998. Impact of anti H influenzae type b vaccine;Tendencias en la etiología de la meningitis bacteriana aguda en niños chilenos, período 1989-1998. Impacto de la vacuna anti-H influenzae tipo b (Hib)

Revista Medica de Chile

Volumn 129, Issue 7, 2001, Pages 719-726

  Díaz P, José Manuel ^b   Catalán N, Lía ^b   Urrutia L, María Teresa ^b   Prado J, Valeria ^a   Ledermann D, Walter ^a   Mendoza N, Carmen ^a   Topelberg V, Santiago ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Harmophilus influenzae type b; Meningitis haemophily; Meningitis, bacterial; Vaccination

Indexed keywords

HAEMOPHILUS VACCINE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; BACTERIAL MENINGITIS; CHILD; CHILE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOLOGY; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHILE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGITIS, BACTERIAL; RETROSPECTIVE STUDIES;

EID: 0035404497     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. COFRÉ J. Taller: Meningitis bacteriana aguda (parte I). Rev Chile Infect 1991; 8: 61-73.
2. O'RYAN M. Vacunas anti Haemophilus influenzae tipo B. Rev Chile Infect 1995; 12: 63-6.
3. CHÁVEZ A, ROJAS C, COHEN L, CHADID J. Infecciones invasoras por H influenzae B. Rev Chile Infect 1996; 13: 27-33.
4. CHÁVEZ A, ROJAS C, RAKELA S, CHADID J, FISHER C. Meningitis bacteriana aguda: experiencia de 10 años. Rev Chile Infect 1994; 11: 92-8.
5. TUNKEN A, SCHELD NM. Therapy of bacterial meningitidis: principles and practice. Infect Control Hosp Epidemiol 1989; 10: 565-9.
6. RIVADENEIRA S, AGUAD L, BENCINI R, PALOMINO C. Meningitis meningocócica: Estudio clínico de 134 casos (1978-1988) Hospital Lucio Córdova. Santiago, Chile. Rev Chile Infect 1989; 6: 76-81.
7. SHAPIRO E, WARD J. The epidemiology and prevention of disease caused by Haemophilus influenzae type B. Epidemiol Rev 1991; 13: 113-42.
8. LUCENA R, GÓMEZ I, FERREIRA A, GOES J, ARAUJO I. Clinical and laboratory characteristics of bacterial meningitis in children. Arq Neuropsiquiat (Brazil) 1996; 54: 571-6.
9. GEDLU E, RAHLENBECK S. Pyogenic meningitis in children in north-western Ethiopia. Ann Trop Paediatr 1995; 15: 243-7.
10. YANG Y, LENG Z, SHEN X, LU D, JIANG Z. Acute bacterial meningitis in children in Hefei, China 1990-1992. Chin Med J 1996; 109: 385-8.
11. FERRECCIO C, ORTIZ E, ASTROZA L, RIVERA C, CLEMENS J, LEVINE M. A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile. Pediatr Infect Dis J 1990; 9: 488-94.
12. BARRAZA P, TOPELBERG S, LAGOS R. Meningitis bacteriana: resultados clínicos. Rev Chil Pediatr 1993; 7: 105-9.
13. SHAPIRO E. Infections caused by Haemophilus influenzae type B. The beginning of the end? JAMA 1993; 269: 264-6.
14. MURPHY T, WHITE K, PASTOR P, GABRIEL L, MEDLEY F, GRANOFF D, OSTERHOLM M. Declining incidence of Haemophilus influenzae type B disease since introduction of vaccination. JAMA 1993; 269: 246-8.
15. WEINBERG G, GRANOFF D. Polyssacharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type B disease. J Pediatr 1988; 113: 621-31.
16. DINTZIS R. Rational design of conjugate vaccines. Pediatr Res 1992; 32: 376-85.
17. GRANOFF D, ANDERSON E, OSTERHOLM M, HOLMES S, Mc HUGH J, BELSHE R ET AL. Differences in the inmunogenicity of three Haemophilus influenzae type B conjugate vaccines in infants. J Pediatr 1992; 121: 187-94.
18. PELTOLA H, AAVISTLAND P, HANSEN K, JÓNSDÓTTIR K, NOKLEBY H, ROMANUS V. Perspective: a five country analysis of the impact of four different Haemophilus influenzae type B conjugates and vaccination strategies in Scandinavia. J Infect Dis 1999; 179: 223-9.
19. O'RYAN M, COFRÉ J. Comunicado del Consejo Consultivo de Inmunizaciones sobre esquemas alternativos de inmunización con vacunas conjugadas contra H influenzae B. Rev Chil Infect 1997; 14: 57-8.
20. BLACK S, SHINEFIELD H, FIREMAN B, HIAH R, POLEN M, VITTINGHOH E. Efficacy in infancy of oligo-saccharide conjugate Haemophilus influenzae type (HbOC) vaccine in a United States population of 61,080 children. Pediatr Infect Dis J 1991; 10: 97-104.
21. Progress toward eliminating Haemophilus infuenzae type B disease among infants and children, United States, 1987-1997. MMWR Morb Mortal Wkly Rep 1998; 47: 993-8.
22. WILLIAM A, DEAVER K, COCHI S, PLICAYTIS B, ZELL E, BROOME C, WENGER J. Decline of childhood Haemophilus influenzae type B (Hib) disease in the Hib vaccine era. JAMA 1993; 269: 221-6.
23. PELTOLA H. Haemophlius influenzae type B disease and vaccination in Europe: lessons learned. Pediatr infect Dis J 1998; 17 ( Suppl): S126-32.
24. SLACK M, AZZOPARDI H, HARGREAVES R, RAMSAY M. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines. Pediatr Infect Dis J 1998; 17 (suppl): S204-7.
25. BOWER C, CONDON R, PAYNE J, BURTON P. Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type B infection in Western Australia. Aust N Z J Public Health 1998; 22: 67-72.
26. WENGER J. Epidemiology of Haemophilus influenzae type B disease and impact of Haemophilus influenzae type B conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998; 17 (Suppl): S132-6.
27. MORANT A, DIEZ J, ROSALES A, MORENO R. Vaccinaton against Haemophilus influenzae type B in the Valencia Community: efficacy and failure of vaccinations. An Esp Pediatr 1998; 48: 352-4.
28. MORANT A, DIEZ J, GIMENO C, DE LA MUELA N, PEREIRO I, BRINES J. Epidemiology of Haemophilus influenzae type B, Neisseria meningitidis and Streptococcus pueumoniae in children in the Valencia Community, Spain. Acute diseases study group. Rev Neurol 1998; 26: 34-7.
29. GARPENHOLT O, SILFVERDAL S, HUGOSSON S, FREDLUND H, BODIN L, ROMANUS V, OLCEN P. The impact of Haemophilus influenzae type B vaccination in Sweden. Scand J Infect Dis 1996; 28: 165-9.
30. VAN ALPHEN L, SPANJAARD L, VAN DER ENDE A, SCHUURMAN I, DANKERT J. Effect of nation wide vaccination of 3 months old infants en The Netherlands with conjugate Haemophilus influenzae type B vaccine: high efficacy and lack of herd immunity. J Pediatr 1997; 131: 869-73.
31. BASSON E, DI MAIO M, STAMM D, CAGNIN S ET AL. Haemophilus influenzae meningitis following vaccination. Consequence or coincidence? Arch Pediatr 1996; 3: 342-4.
32. TAKALA A, ESKOLA J, LEINONEN M, KÄYTHTY H, NISSINEN A, PEKKANEN E, MÄKELA H. Reduction of oropharyngeal carriage of Haemophilus influenzae type D (Hib) in children with Hib conjugate vaccine. J Infect Dis 1991; 164: 982-6.
33. ADEGBOLA R, MULHOLLAND E, SECKA O, JAFFAR S, GREENWOOD B. Vaccination with a Haemophilus influenzae type B conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type B among Gambian children. J Infect Dis 1998; 177: 1758-61.
34. BARBOUR M, MAYON-WHITE R, COLES C, CROOK D, MOXON E. The impact of conjugate vaccine on carriage of Haemophilus influenzae type B. J Infect Dis 1995; 171: 93-8.
35. GÓMEZ E, MOORE A, SÁNCHEZ J, KOOL J, CASTELLANOS L, FERIS J ET AL. The epidemiology of Haemophilus influenzae type B carriage among infants and young children in Santo Domingo, Dominican Republic. Pediatr Infect Dis J 1998; 17: 782-6.
36. FLEISHER G, PLATT R, AND THE OCCULT BACTEREMIA STUDY GROUP. Intramuscular antibiotic therapy for prevention of bacterial sequelae in children with occult bacteremia. Pediatr Res 1992; 31: 161.
37. PELTOLA H. Haemopbilus influenzae type B disease and vaccination in Latin America and the Caribbean. Pediatr Infect Dis J 1997; 16: 780-7.